In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2.

Satyajit Beura,Chetti Prabhakar

In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2.

2020

Satyajit Beura
Chetti Prabhakar

The global health emergency of novel COVID-19 is due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Currently there are no approved drugs for the treatment of coronaviral disease ...

Keywords:

severe acute respiratory syndrome coronavirus 2
Virology
Global health
Chloroquine
Molecular biology
Disease
Docking (molecular)
Coronavirus disease 2019
In silico
Chemistry
2019 20 coronavirus outbreak
Biochemistry

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations